INTC
33
-2
CRM
67
2
AON
54
2
GE
67
2
NDAQ
62
2
ADSK
70
2
SCHW
62
-2
JWN
48
6
MAS
58
2
PFE
23
7
UA
50
-9
PAYX
53
2
VMC
57
4
FE
50
-2
F
58
11
CA
38
6
URI
65
5
INTU
56
-4
CTSH
56
2
LNC
39
3
INTC
33
-2
CRM
67
2
AON
54
2
GE
67
2
NDAQ
62
2
ADSK
70
2
SCHW
62
-2
JWN
48
6
MAS
58
2
PFE
23
7
UA
50
-9
PAYX
53
2
VMC
57
4
FE
50
-2
F
58
11
CA
38
6
URI
65
5
INTU
56
-4
CTSH
56
2
LNC
39
3
Financhill
Back

Regeneron Pharmaceuticals Vs. Biogen Industry Stock Comparison

Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
737.85
Seasonality Move:
14.6%
Sell
28

BIIB
Biogen

Last Price:
157.84
Seasonality Move:
12.81%
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $738.00. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $157.90. The Score for BIIB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $738.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $157.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing slight selling pressure.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -60.82 Sell
Relative Strength Index (14 RSI): 13.13 Sell
Chaikin Money Flow: -973600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (767.55 - 916.07) Sell
Bollinger Bands (100): (904.84 - 1161.96) Sell

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.69 Sell
Relative Strength Index (14 RSI): 24.44 Sell
Chaikin Money Flow: -837030 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (162.16 - 182.18) Sell
Bollinger Bands (100): (177.63 - 215.81) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 759.51 Sell
20-day SMA: 815.56 Sell
50-day SMA: 948.17 Sell
200-day SMA: 1001.38 Sell
8-day EMA: 761.76 Sell
20-day EMA: 815.61 Sell
50-day EMA: 913.33 Sell
200-day EMA: 973.48 Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 159.49 Sell
20-day SMA: 169.26 Sell
50-day SMA: 181.96 Sell
200-day SMA: 208.06 Sell
8-day EMA: 160.27 Sell
20-day EMA: 167.71 Sell
50-day EMA: 179.71 Sell
200-day EMA: 207.11 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $0.26 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):